Ultrastructural features and P-glycoprotein immunolocalization in Saos-2/DX580 multidrug-resistant human osteosarcoma cells

Journal of Submicroscopic Cytology and Pathology

Volumn 28, Issue 1, 1996, Pages 93-100

  Maraldi, N M ^a,b,c   Zini, N ^a   Sabatelli, P ^a   Valmori, A ^a   Scotlandi, K ^b   Serra, M ^b   Baldini, N ^b  

^a CNR   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Electron microscopy; Human osteosarcoma; Immunogold; Multidrug resistance; Nuclear matrix; P glycoprotein

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; TUMOR PROTEIN;

ARTICLE; BONE TUMOR; CELL CULTURE; CELL MEMBRANE; CELL NUCLEUS MATRIX; CHEMISTRY; CHROMATIN; DRUG EFFECT; DRUG RESISTANCE; ELECTRON MICROSCOPY; HUMAN; MULTIDRUG RESISTANCE; OSTEOSARCOMA; PATHOLOGY; ULTRASTRUCTURE;

BONE NEOPLASMS; CELL MEMBRANE; CHROMATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROSCOPY, ELECTRON; NEOPLASM PROTEINS; NUCLEAR MATRIX; OSTEOSARCOMA; P-GLYCOPROTEIN; TUMOR CELLS, CULTURED;

EID: 0030019144     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BALDINI N., SCOTLANDI K., SERRA M., SHIKITA T., ZINI N., OGNIBENE A., SANTI S., FERRACINI R. and MARALDI N.M., 1995. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur. J. Cell. Biol., 68, 226-239.
2. BOBICHON H., OKIEMI M., BROCLIO C., PLOTON D. and DUFFR J., 1992. Adriamycin resistance is characterized by ultrastructural changes in human leukaemic K562 cells in vitro. Biol. Cell., 74, 287-297.
3. CHEN C.J., CHIN J.E., UEDA K., CLARK D.P., PASTAN I., GOTTESMANN M.M. and RONINSON I.B., 1986. Internal duplication and homology with bacterial transport proteins in the mdrl (P-glycoprotein) gene from multidrug-resistant cells. Cell, 47, 381-389.
4. CHOU T.H. and YOST C., 1985. Adriamycin resistance in murine leukemia P388 cells and increased DNA repair. Proc. Am. Assoc. Cancer Res., 26, 855 (abstr.).
5. DE VORE R.F., CORBETT A.H. and OSHEROEF N., 1992. Phosphorylation of topoisomerase II by casein kinase II and protein kinase C: effects on enzyme-mediated DNA cleavage/religation and sensitivity to the antineoplastic drug etoposide and 4'-(9-acridinylamino)methanesulfon-m-anisidide. Cancer Res., 52, 2156-2161.
6. DIVECHA N., BANFIC H. and IRVINE R., 1993. Inositides and the nucleus and inositides in the nucleus. Cell, 74, 405-407.
7. DUFER J., AKELI M.G., JEANNESSON P., DESPLACES A. and JARDILLIER J.C., 1989. Quantitative morphological analysis of adriamycin-resistant human K562 leukemic cells. Cytometry, 10, 37-43.
8. PACCHINETTI T., MALISANO G., SALARDI S., GERONI C., BELLINI O., ESPOSITO G. and GIULIANI F.C., 1985. Biochemical and morphological studies in P388 sensitive and doxorubicin resistant (P388/DX) leukemia cells. Proc. Am. Assoc. Cancer Res., 26, 343 (abstr.).
9. FOJO A., CORNWELL M., CARDARELLI C., CLARK D.P., RICHER N., SHEN D.W., VEDA K., WILLINGHAM M., GOTTESMAN M.M. and PASTAN I., 1987. Molecular biology of drug resistance. Breast Cancer Res., 9, 5-16.
10. GOTTESMAN M.M. and PASTAN I., 1993. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427.
11. GROS P., CROOP J., RONINSON I., VARSHAVSKY A. and HOUSMAN D.E., 1986. Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells. Proc. Natl. Acad. Sci. USA, 83, 337-341.
12. JULIANO R.L. and LING V., 1976. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162.
13. KOMITOVSKI D., SONKA J., SCHMITT B. and MUTO S., 1985. Quantitative description of nuclear morphology in assessing resistance of sarcoma 180 to adriamycin. Cytometry, 8, 625-631.
14. MANCINI M.A., SHAN B., NICKERSON J.A., PENMAN S. and LEE W.H., 1994. The retinoblastoma gene product is a cell-cycle-dependent, nuclear matrix-associated protein. Proc. Natl. Acad Sci. USA, 91, 418-422.
15. MARALDI N.M., ZINI N., SQUARZONI S., DEL COCO R., SABATELLI P. and MANZOLI F.A., 1992. Intranuclear localization of phospholipids by ultrastructural cytochemistry. J. Histochem. Cytochem., 40, 1383-1392.
16. MARTELLI A.M., GILMOUR R.S., BERTAGNOLO V., NERI L., MANZOLI L. and COCCO L., 1992. Nuclear localization and signalling activity of phosphoinositidase C ß in Swiss 3T3 cells. Nature, 358, 242-245.
17. MORROW C.S. and COWAN K.H., 1993. Drug-resistance and cancer. Adv. Exp. Med. Biol., 33, 287-305.
18. SEBTI S.M., JANI J.P., MISTRY J.S., GORELIK E. and LAZO J.S., 1991. Metabolic inactivation, a mechanism of human tumour resistance to bleomycin. Cancer Res., 51, 227-232.
19. SERRA M., SCOTLANDI K., MANARA M.C., MAURICI D., LOLLINI P.L., DE GIOVANNI C., TOFFOLI G. and BALDINI N., 1993. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines. Anticancer Res., 13, 323-330.
20. SIMPKINS H., LEHMAN J.M., MAZURKIEWICZ J.E. and DAVIES B.N., 1991. A morphological and phenotypic analysis of Walker 256 cells. Cancer Res., 51, 1334-1338.
21. TSURUO T., UEDA H., OHKOCHI E., TSUKAGOSHI S. and SAKURAI Y., 1983. Establishment and properties of vincristine-resistant human myelogenous leukemia K562. Gann, 74, 751-758.
22. ZINI N., MARTELLI A.M., COCCO L., MANZOLI F.A. and MARALDI N.M., 1993. Phosphoinositidase C isoforms are specifically localized in the nuclear matrix and cytoskeleton of Swiss 3T3 cells. Exp. Cell Res., 208, 257-269.
23. ZINI N., SCOTLANDI K., BALDINI N., MINI G., SABATELLI P. and MARALDI N.M., 1995. Multidrug resistance (MDR) phenotype of human osteosarcoma cells evaluated by quantitative morphological and electron microscopy analyses. Biol. Cell, 84.